Literature DB >> 1666002

Unicompartmental replacement with the Marmor Modular knee: operative procedure and results.

T Koshino1, T Morii, J Wada, S Takahashi.   

Abstract

Unicompartmental arthroplasty using the Marmor Modular knee was performed in 27 knees of 24 patients--three men and 21 women--aged 51-82 years (average age 68.9 years). The disease was osteoarthritis in 19 knees, steroid arthropathy in two knees, Charcot joint in three knees, and rheumatoid arthritis in three knees. Medial replacement was done in 24 knees and lateral replacement in three knees. Follow-up was from 2-7 years (average 4 years 9 months). Post-operatively, 14 knees were reported to be free of pain and 11 only occasionally mildly painful. Walking distance improved to more than 1 km in 17 patients. The knee score improved from 40.4 to 72.2 points (p less than 0.01). Complications included two knees with loosening due to postoperative limb malalignment; there were no instances of infection or fracture.

Entities:  

Mesh:

Year:  1991        PMID: 1666002

Source DB:  PubMed          Journal:  Bull Hosp Jt Dis Orthop Inst        ISSN: 0883-9344


  3 in total

Review 1.  Causes of revision following Oxford phase 3 unicompartmental knee arthroplasty.

Authors:  Seung-Ju Kim; Ricardo Postigo; Sowon Koo; Jong Hun Kim
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-09-01       Impact factor: 4.342

2.  Longitudinal changes in body mass index of children affected by the Great East Japan Earthquake.

Authors:  W Zheng; H Yokomichi; H Matsubara; M Ishikuro; M Kikuya; T Isojima; S Yokoya; T Tanaka; N Kato; S Chida; A Ono; M Hosoya; S Tanaka; S Kuriyama; S Kure; Z Yamagata
Journal:  Int J Obes (Lond)       Date:  2017-01-17       Impact factor: 5.095

3.  Clinical results of unicompartmental arthroplasty for knee osteoarthritis using a tibial component with screw fixation.

Authors:  Tomihisa Koshino; Koji Sato; Yusuke Umemoto; Yasushi Akamatsu; Ken Kumagai; Tomoyuki Saito
Journal:  Int Orthop       Date:  2014-10-24       Impact factor: 3.075

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.